Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-26 @ 2:09 AM
NCT ID:
NCT02657005
Pre Assignment Details:
Once an appropriate patient has been identified, a 30-day screening period began and evaluated eligibility.
The study was executed in several Parts:
Part 1: Dose Escalation Segment (Cohorts 1-6) Part 2: Schedule Escalation Segment (Cohorts 7-9) Part 3: Expansion Segment (Cohort 10) Part 4: Dose and Schedule Evaluation Segment (Cohort 11)
Note: For purposes of result summaries, Cohorts 1-8 pooled, Cohorts 9 \& 10 pooled, and Cohort 11 will be displayed.
Recruitment Details:
85 subjects were enrolled in this study across eight North American centers. The pathologic diagnoses were confirmed at each enrolling center. Most patients were heavily pretreated, with the median number of prior therapies being 3.0 (range, 1-10). The gender and ethnicity of the enrolled patients matched ES's prevalence in the U.S. population.
Study:
NCT02657005
Study Brief:
Results Section:
NCT02657005